to attack cancer cells specifically by blocking their ability to grow and spread(passive) is designedTargeted therapy

the gene biomarkers ... can helpdesigntargeted therapy

to deliver a substance preferentially to the organ in order to increase the accumulation , improve the therapeutic effect and reduce toxicity to other organs(passive) is designedtargeted therapy

to slow the growth of the tumor by “ targeting ” one or more steps in the cancer ’s growth process(passive) is designedTargeted therapy

to target abnormal molecular pathways in a subgroup of patients with a given cancer diagnosis ( 6(passive) are scientifically designedTargeted therapy

to target a specific alteration / mutation and produce anticancer effect by selectively modifying a target key to the growth of cancer cells(passive) is designedTargeted therapy

to target cancer cells with specific molecular abnormality(passive) is designedTargeted therapy

that an induced " perturbed " metabolic state ,resultingfrom targeted therapy

to alter specific abnormalities present within cancer cells(passive) is designedTargeted therapy

to target abnormalities commonly seen in cancer cells(passive) is designedTargeted Therapy

to stop potential problem cells from reproducing and forming tumors(passive) is designedTargeted therapy

to identify and attack specific cancer cells without harming normal cells(passive) is designedTargeted therapy

to focus healing light to the affected skin(passive) is designedTargeted therapy

Steve hun Shazer , Insoo Kim Berg , and(passive) designed byTargeted therapy

to stop or slow the growth of cancer by interfering with , or targeting , molecules or genes in cancer cells that help the disease survive , grow and spread(passive) is designedTargeted therapy

to interfere with a specific gene , pathway or process in a tumor(passive) can be designedA targeted therapy

by contrast(passive) is designedTargeted therapy

to treat only the cancer cells and minimize damage to normal , healthy cells(passive) is designedA targeted therapy

to identify the cancer mutations and then block their growth pathway(passive) is designedA targeted therapy

to target only cancer cells so that there is minimal damage to the healthy cells(passive) is designedTargeted therapy

to attack the molecular changes that make cancer cells grow and spread(passive) is designedTargeted therapy

in which an individual patient ’s tumor is screenedto createa targeted therapy

to attack and kill only the cancer cells , while sparing the rest of the body from the collateral damage common to traditional chemotherapy(passive) is designedTargeted therapy

This bidirectional interaction should be taken into accountwhen designingtherapy targeting

to stop potential problems solves from reproducing and forming cancer(passive) is designedTargeted therapy

particular genetic alterations(passive) is caused byTargeted therapy

to identify receptors and proteins unique to specific cancer cells(passive) is designedTargeted therapy

Ctc monitoringcan leadtargeted therapy

to block a specific gene or protein that has a critical role in the survival , growth , invasion , or metatasis of a specific cancer cell(passive) is designedTargeted ' therapy

reactive oxygen species Jorge Peiró Cadahía , a Viola Previtali(passive) triggered bytargeted therapy

an epigenetic signature for each tumor type ... using these signaturesto designtargeted therapy

to deliver agents to malignant cells and spare normal cells(passive) is designedTargeted therapy

to destroy and influence cancer cells without affecting normal , non - cancerous cells(passive) is designedTargeted therapy

that fuse an antibody to a cell - killing payloadto createa targeted therapy

on the basis of a knowledge of which mutations are present at any given time , and a precise and highly personalized treatment plan for each patient can be developed(passive) can thus be designedTargeted therapy

Thiel 's investment in Stemcentrx , a company utilizing our increasing knowledge of stem cell driven tumor evolutionto createtargeted therapy

exploiting the genetic differences between normal and tumor cells(passive) has been discovered byTargeted therapy

that fuse an antibody to a tumor - killing payloadto createa targeted therapy

kaput ... helpsdesigntargeted therapy

to spare healthy cells(passive) is designedTargeted therapy